Bill > SB5401

This bill aims to increase prescription drug cost transparency in Washington state. It requires health insurance issuers to submit data on the most frequently prescribed, costliest, and fastest-rising prescription drugs, as well as the impact of drug costs on premiums. It also requires drug manufacturers to report detailed information on the costs and pricing of drugs with high launch prices or significant price increases. The collected data will be compiled into an annual report for the public and legislature, with the goal of understanding the drivers of prescription drug costs and informing efforts to contain those costs and improve consumer access to needed drugs.